3.4900.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Financials
Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BIOSTAR PHARM-B(02563) the Revenue is 21.16 M (+161.2%);the EBIT is -11.48 M (+65.82%);the EPS is -0.0421 (+48.74%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B161.16%
----
----
EBIT
-0.01B65.82%
----
----
EPS
-0.042148.74%
----
----
Upcoming earnings report - FY2026 Q3 Earning Release
Available dateNov 26, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
